Nigel J Murtagh sold $4.1M of SCHW
Chief Risk Officer at SCHWAB CHARLES CORP. 41,297 shares at an average of $99.00, traded Apr 14, 2026, filed Apr 15, 2026.
Score components
- +15RoleOfficer
- +25Trade size$4.1M at market
- +10Share of holdings soldSold 42% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -9.0%, 3m +2.9%, 6m -2.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001649599-26-000006, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 14, 2026 | MOption exercise Common Stock10b5-1 | +41,297 | $52.05 | $2.1M | 99,269 | Apr 15, 2026 |
| Apr 14, 2026 | SOpen-market sale Common Stock10b5-1 | -41,297 | $99.00 | $4.1M | 57,972 | Apr 15, 2026 |
| Apr 14, 2026 | MOption exercise Nonqualified Stock Option (right to buy)derivative10b5-1 | -41,297 | $0.00 | $0 | 0 | Apr 15, 2026 |
Related signals
Other insiders at SCHWAB CHARLES CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 8Weak | SCHWAB CHARLES CORP | Neesha Hathi MD, Head Wealth Adv, Bnk, Tst | $489k 5,000 shares | -46% | |
| 20Weak | SCHWAB CHARLES CORP | Neesha Hathi MD, Head Wealth Adv, Bnk, Tst | $346k 3,177 shares | -36% | |
| 50Moderate | SCHWAB CHARLES CORP | Walter W Bettinger Co-Chairman | $8.3M 74,388 shares | -11% | |
| 30Weak | SCHWAB CHARLES CORP | Neesha Hathi MD, Head Wealth Adv, Bnk, Tst | $343k 3,177 shares | -100% | |
| 55Moderate | SCHWAB CHARLES CORP | Carolyn Schwab-Pomerantz director | $1.0M 9,175 shares | -1% | |
| 50Moderate | SCHWAB CHARLES CORP | Walter W Bettinger Co-Chairman | $20M 176,210 shares | -22% | |
| 60Notable | SCHWAB CHARLES CORP | Charles R. Schwab Co-Chairman | $13M 117,000 shares | -0% | |
| 40Moderate | SCHWAB CHARLES CORP | Jonathan S Beatty MD, Head of Advisor Services | $111k 1,000 shares | -9% | |
| 40Moderate | SCHWAB CHARLES CORP | Jonathan M. Craig MD, Head of Retail Investing | $2.4M 21,866 shares | -100% | |
| 28Weak | SCHWAB CHARLES CORP | Dennis Howard MD, Chief Tech, OPS & Data Off | $242k 2,198 shares | -24% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.